169 related articles for article (PubMed ID: 20688625)
21. Hyperbaric oxygen in the treatment of radiation-induced optic neuropathy.
Guy J; Schatz NJ
Ophthalmology; 1986 Aug; 93(8):1083-8. PubMed ID: 3763158
[TBL] [Abstract][Full Text] [Related]
22. Inefficiency of the anticoagulant therapy in the regression of the radiation-induced optic neuropathy in Cushing's disease.
Barbosa AP; Carvalho D; Marques L; Monteiro M; Castro Neves A; Machado Carvalho A; Cruz J; Medina JL
J Endocrinol Invest; 1999 Apr; 22(4):301-5. PubMed ID: 10342365
[TBL] [Abstract][Full Text] [Related]
23. The therapy of Cushing's disease in adults and children: an update.
Juszczak A; Ertorer ME; Grossman A
Horm Metab Res; 2013 Feb; 45(2):109-17. PubMed ID: 23225246
[TBL] [Abstract][Full Text] [Related]
24. Pituitary radiotherapy for Cushing's disease.
Losa M; Picozzi P; Redaelli MG; Laurenzi A; Mortini P
Neuroendocrinology; 2010; 92 Suppl 1():107-10. PubMed ID: 20829629
[TBL] [Abstract][Full Text] [Related]
25. Radiation-induced optic neuropathy.
Danesh-Meyer HV
J Clin Neurosci; 2008 Feb; 15(2):95-100. PubMed ID: 18068989
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Factors of Long-Term Remission After Surgical Treatment of Cushing's Disease.
Ioachimescu AG
Endocrinol Metab Clin North Am; 2018 Jun; 47(2):335-347. PubMed ID: 29754635
[TBL] [Abstract][Full Text] [Related]
27. Early bilateral radiation-induced optic neuropathy with follow-up MRI.
McClellan RL; el Gammal T; Kline LB
Neuroradiology; 1995 Feb; 37(2):131-3. PubMed ID: 7760999
[TBL] [Abstract][Full Text] [Related]
28. P53 gene mutation in an atypical corticotroph adenoma with Cushing's disease.
Kawashima ST; Usui T; Sano T; Iogawa H; Hagiwara H; Tamanaha T; Tagami T; Naruse M; Hojo M; Takahashi JA; Shimatsu A
Clin Endocrinol (Oxf); 2009 Apr; 70(4):656-7. PubMed ID: 18771563
[No Abstract] [Full Text] [Related]
29. Target delineation and optimal radiosurgical dose for pituitary tumors.
Minniti G; Osti MF; Niyazi M
Radiat Oncol; 2016 Oct; 11(1):135. PubMed ID: 27729088
[TBL] [Abstract][Full Text] [Related]
30. Case report: hyperbaric oxygen and MRI findings in radiation-induced optic neuropathy.
Li CQ; Gerson S; Snyder B
Undersea Hyperb Med; 2014; 41(1):59-63. PubMed ID: 24649718
[TBL] [Abstract][Full Text] [Related]
31. Optic neuropathy secondary to radiotherapy for nasal melanoma.
Garrott H; O'Day J
Clin Exp Ophthalmol; 2004 Jun; 32(3):330-3. PubMed ID: 15180849
[TBL] [Abstract][Full Text] [Related]
32. Should patients with radiation-induced optic neuropathy receive any treatment?
Lee MS; Borruat FX
J Neuroophthalmol; 2011 Mar; 31(1):83-8. PubMed ID: 21317734
[No Abstract] [Full Text] [Related]
33. Delayed optic nerve complications after proton beam irradiation.
Chacko JG; Schatz NJ; Glaser JS
Ann Ophthalmol (Skokie); 2008; 40(3-4):166-70. PubMed ID: 19230355
[TBL] [Abstract][Full Text] [Related]
34. Clinical management of critically ill patients with Cushing's disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide.
Cannavo S; Messina E; Albani A; Ferrau F; Barresi V; Priola S; Esposito F; Angileri F
Endocrine; 2016 Jun; 52(3):481-7. PubMed ID: 25877016
[TBL] [Abstract][Full Text] [Related]
35. Relapsing, remitting hypercortisolism in Cushing's disease due to intratumoral hemorrhages in pituitary microadenoma.
Marko NF; Hamrahian AH; Hatipoglu B; Weil RJ
J Clin Neurosci; 2013 May; 20(5):753-6. PubMed ID: 23352667
[TBL] [Abstract][Full Text] [Related]
36. Hyperbaric oxygen therapy for radiation-induced optic neuropathy.
Levy RL; Miller NR
Ann Acad Med Singap; 2006 Mar; 35(3):151-7. PubMed ID: 16625263
[TBL] [Abstract][Full Text] [Related]
37. Reversible "brain atrophy" in patients with Cushing's disease.
Gnjidić Z; Sajko T; Kudelić N; Malenica M; Vizner B; Vrkljan M; Hat J; Rumboldt Z
Coll Antropol; 2008 Dec; 32(4):1165-70. PubMed ID: 19149224
[TBL] [Abstract][Full Text] [Related]
38. Lack of radiation optic neuropathy in 72 patients treated for pituitary adenoma.
van den Bergh AC; Schoorl MA; Dullaart RP; van der Vliet AM; Szabó BG; ter Weeme CA; Pott JW
J Neuroophthalmol; 2004 Sep; 24(3):200-5. PubMed ID: 15348984
[TBL] [Abstract][Full Text] [Related]
39. [Predictors of long-term remission after transsphenoidal surgery in Cushing's disease].
Abellán Galiana P; Fajardo Montañana C; Riesgo Suárez PA; Gómez Vela J; Escrivá CM; Lillo VR
Endocrinol Nutr; 2013 Oct; 60(8):475-82. PubMed ID: 23266144
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of Cushing's disease. Transsphenoidal surgery and pituitary radiotherapy].
Lamas Oliveira C; Estrada García J
Endocrinol Nutr; 2009 Mar; 56(3):123-31. PubMed ID: 19627725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
